{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:35:04Z","timestamp":1794562504114,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074479"],"award-info":[{"award-number":["82074479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterized by chronic low-grade inflammation. Previous studies have demonstrated that the gut microbiome can affect the host tissue cells\u2019 mRNA N6-methyladenosine (m6A) modifications. This study aimed to understand the role of intestinal flora in ovarian cells inflammation by regulating mRNA m6A modification particularly the inflammatory state in PCOS. The gut microbiome composition of PCOS and Control groups was analyzed by 16S rRNA sequencing, and the\u00a0short chain fatty acids were detected in patients\u2019 serum by mass spectrometry methods. The level of butyric acid was found to be decreased in the serum of the obese PCOS group (FAT) compared to other groups, and this was correlated with increased Streptococcaceae and decreased Rikenellaceae based on the Spearman\u2019s rank test. Additionally, we identified FOSL2 as a potential METTL3 target using RNA-seq and MeRIP-seq methodologies. Cellular experiments demonstrated that the addition of butyric acid led to a decrease in FOSL2 m6A methylation levels and mRNA expression by suppressing the expression of METTL3, an m6A methyltransferase. Additionally, NLRP3 protein expression and the expression of inflammatory cytokines (IL-6 and TNF-\u03b1) were downregulated in KGN cells. Butyric acid supplementation in obese PCOS mice improved ovarian function and decreased the expression of local inflammatory factors in the ovary. Taken together, the correlation between the gut microbiome and PCOS may unveil crucial mechanisms for the role of specific gut microbiota in the pathogenesis of PCOS. Furthermore, butyric acid may present new prospects for future PCOS treatments.<\/jats:p>","DOI":"10.1186\/s13148-023-01487-9","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:14:11Z","timestamp":1684156451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome"],"prefix":"10.1186","volume":"15","author":[{"given":"Kailu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"key":"1487_CR2","doi-asserted-by":"publisher","first-page":"970733","DOI":"10.3389\/fendo.2022.970733","volume":"13","author":"J Yu","year":"2023","unstructured":"Yu J, et al. Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;13:970733.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1487_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcp.29912","volume":"236","author":"M Rostamtabar","year":"2021","unstructured":"Rostamtabar M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol. 2021;236:824\u201338. https:\/\/doi.org\/10.1002\/jcp.29912.","journal-title":"J Cell Physiol"},{"key":"1487_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00281-019-00737-4","volume":"41","author":"M Popovic","year":"2019","unstructured":"Popovic M, Sartorius G, Christ-Crain M. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1? Semin Immunopathol. 2019;41:447\u201359. https:\/\/doi.org\/10.1007\/s00281-019-00737-4.","journal-title":"Semin Immunopathol"},{"key":"1487_CR5","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1002\/jcp.27501","volume":"234","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. J Cell Physiol. 2019;234:7435\u201347.","journal-title":"J Cell Physiol"},{"key":"1487_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"1487_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00450-x","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Targeted Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Targeted Ther"},{"key":"1487_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18\u201329.","journal-title":"Mol Cell"},{"key":"1487_CR9","doi-asserted-by":"publisher","first-page":"e1007412","DOI":"10.1371\/journal.pgen.1007412","volume":"14","author":"SD Kasowitz","year":"2018","unstructured":"Kasowitz SD, et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 2018;14:e1007412.","journal-title":"PLoS Genet"},{"key":"1487_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.670711","author":"J Luo","year":"2021","unstructured":"Luo J, Xu T, Sun K. N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.670711.","journal-title":"Front Cell Dev Biol"},{"key":"1487_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000001550","author":"L Wen","year":"2020","unstructured":"Wen L, et al. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6\/NF-\u03baB pathway. Neurosport. 2020. https:\/\/doi.org\/10.1097\/WNR.0000000000001550.","journal-title":"Neurosport"},{"key":"1487_CR12","first-page":"839","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, et al. METTL3\/METTL14 transactivation and m6A-dependent TGF-\u03b21 translation in activated kupffer cells. Cmgh. 2021;12:839\u201356.","journal-title":"Cmgh"},{"key":"1487_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15126-x","volume":"11","author":"S Jabs","year":"2020","unstructured":"Jabs S, et al. Impact of the gut microbiota on the m6A epitranscriptome of mouse cecum and liver. Nat Commun. 2020;11:1\u201316.","journal-title":"Nat Commun"},{"key":"1487_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41422-018-0127-2","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Transcriptome-wide reprogramming of N6-methyladenosine modification by the mouse microbiome. Cell Res. 2019;29:167\u201370.","journal-title":"Cell Res"},{"key":"1487_CR15","first-page":"515","volume":"17","author":"S Starling","year":"2021","unstructured":"Starling S. Key role for gut microbiota in PCOS development. Nat Rev Endocrinol. 2021;17:515.","journal-title":"Nat Rev Endocrinol"},{"key":"1487_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EC-19-0522","volume":"9","author":"L Zhou","year":"2020","unstructured":"Zhou L, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect. 2020;9:63\u201373.","journal-title":"Endocr Connect"},{"key":"1487_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1894070","volume":"13","author":"X Qi","year":"2021","unstructured":"Qi X, Yun C, Pang Y, Qiao J. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes. 2021;13:1\u201321. https:\/\/doi.org\/10.1080\/19490976.2021.1894070.","journal-title":"Gut Microbes"},{"key":"1487_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4274\/tjod.galenos.2022.29498","volume":"19","author":"\u00d6\u00d6 Ba\u015fer","year":"2022","unstructured":"Ba\u015fer \u00d6\u00d6, G\u00f6\u00e7men AY, K\u0131rm\u0131z\u0131 DA. The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome. Turk J Obstet Gynecol. 2022;19:229\u201335.","journal-title":"Turk J Obstet Gynecol"},{"key":"1487_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14715\/cmb\/2021.67.5.6","volume":"67","author":"P Zhong","year":"2021","unstructured":"Zhong P, Guan B, Lin Y, Zhang S. Changes in inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with polycystic ovary syndrome. Cell Mol Biol. 2021;67:45\u201350.","journal-title":"Cell Mol Biol"},{"key":"1487_CR20","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0405","volume":"232","author":"A Krishnan","year":"2017","unstructured":"Krishnan A, Muthusami S. Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol. 2017;232:R99\u2013113. https:\/\/doi.org\/10.1530\/JOE-16-0405.","journal-title":"J Endocrinol"},{"key":"1487_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead053","author":"LJ Dobbie","year":"2023","unstructured":"Dobbie LJ, et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod. 2023. https:\/\/doi.org\/10.1093\/humrep\/dead053.","journal-title":"Hum Reprod"},{"key":"1487_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","volume":"106","author":"SS Merkin","year":"2016","unstructured":"Merkin SS, Phy JL, Sites CK, Yang D. Environmental determinants of\u00a0polycystic ovary syndrome. Fertil Steril. 2016;106:16\u201324. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.011.","journal-title":"Fertil Steril"},{"key":"1487_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S0954422416000287","volume":"30","author":"YM Jeanes","year":"2017","unstructured":"Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017;30:97\u2013105. https:\/\/doi.org\/10.1017\/S0954422416000287.","journal-title":"Nutr Res Rev"},{"key":"1487_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270\u201384. https:\/\/doi.org\/10.1038\/nrendo.2018.24.","journal-title":"Nat Rev Endocrinol"},{"key":"1487_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/ijamh-2021-0073","volume":"34","author":"M Zehravi","year":"2022","unstructured":"Zehravi M, Maqbool M, Ara I. Polycystic ovary syndrome and infertility: an update. Int J Adolesc Med Health. 2022;34:1\u20139. https:\/\/doi.org\/10.1515\/ijamh-2021-0073.","journal-title":"Int J Adolesc Med Health"},{"key":"1487_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Y, Liu Y, Long S, Mo Z. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"},{"key":"1487_CR27","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/REP-18-0583","volume":"158","author":"AP Snider","year":"2019","unstructured":"Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019;158:R79\u201390.","journal-title":"Reproduction"},{"key":"1487_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1933719114561552","volume":"22","author":"MMB Schulte","year":"2015","unstructured":"Schulte MMB, Tsai JH, Moley KH. Obesity and PCOS: The effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci. 2015;22:6\u201314.","journal-title":"Reprod Sci"},{"key":"1487_CR29","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","volume":"151","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022;151:103628.","journal-title":"J Reprod Immunol"},{"key":"1487_CR30","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1007\/s11033-022-07695-5","volume":"49","author":"M Shamsi","year":"2022","unstructured":"Shamsi M, et al. The immune system\u2019s role in PCOS. Mol Biol Rep. 2022;49:10689\u2013702. https:\/\/doi.org\/10.1007\/s11033-022-07695-5.","journal-title":"Mol Biol Rep"},{"key":"1487_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fendo.2019.00879","volume":"10","author":"F Cirillo","year":"2019","unstructured":"Cirillo F, et al. MiRNAs regulating insulin sensitivity are dysregulated in polycystic ovary syndrome (PCOS) ovaries and are associated with markers of inflammation and insulin sensitivity. Front Endocrinol (Lausanne). 2019;10:879.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1487_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19396368.2020.1860155","volume":"67","author":"H Fu","year":"2021","unstructured":"Fu H, Lin Y, Deng X, Wu L. Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. Syst Biol Reprod Med. 2021;67:112\u201320.","journal-title":"Syst Biol Reprod Med"},{"key":"1487_CR33","doi-asserted-by":"publisher","first-page":"9511772","DOI":"10.1155\/2021\/9511772","volume":"2021","author":"M Ou","year":"2021","unstructured":"Ou M, Xu P, Lin H, Ma K, Liu M. AMH is a good predictor of metabolic risk in women with PCOS: a cross-sectional study. Int J Endocrinol. 2021;2021:9511772.","journal-title":"Int J Endocrinol"},{"key":"1487_CR34","doi-asserted-by":"publisher","first-page":"e0235404","DOI":"10.1371\/journal.pone.0235404","volume":"15","author":"H Kuang","year":"2020","unstructured":"Kuang H, et al. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS ONE. 2020;15:e0235404.","journal-title":"PLoS ONE"},{"key":"1487_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/met.2021.0149","volume":"20","author":"V Salamun","year":"2022","unstructured":"Salamun V, et al. The endometrial transcriptome of metabolic and inflammatory pathways during the window of implantation is deranged in infertile obese polycystic ovarian syndrome women. Metab Syndr Relat Disord. 2022;20:384\u201394.","journal-title":"Metab Syndr Relat Disord"},{"key":"1487_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14904","author":"ASM Moin","year":"2023","unstructured":"Moin ASM, Sathyapalan T, Butler AE, Atkin SL. Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity. Clin Endocrinol (Oxf). 2023. https:\/\/doi.org\/10.1111\/cen.14904.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1487_CR37","doi-asserted-by":"publisher","first-page":"108365","DOI":"10.1016\/j.jnutbio.2020.108365","volume":"80","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis. J Nutr Biochem. 2020;80:108365.","journal-title":"J Nutr Biochem"},{"key":"1487_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","volume":"170","author":"B Zeng","year":"2019","unstructured":"Zeng B, et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res Microbiol. 2019;170:43\u201352.","journal-title":"Res Microbiol"},{"key":"1487_CR39","first-page":"324","volume":"8","author":"R Liu","year":"2017","unstructured":"Liu R, et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbiol. 2017;8:324.","journal-title":"Front Microbiol"},{"key":"1487_CR40","doi-asserted-by":"publisher","first-page":"108717","DOI":"10.1016\/j.intimp.2022.108717","volume":"107","author":"J Huang","year":"2022","unstructured":"Huang J, et al. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022;107:108717.","journal-title":"Int Immunopharmacol"},{"key":"1487_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqab118","volume":"162","author":"Y-L Yang","year":"2021","unstructured":"Yang Y-L, et al. Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome. Endocrinology. 2021;162:1\u201341.","journal-title":"Endocrinology"},{"key":"1487_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082.","journal-title":"Gut Microbes"},{"key":"1487_CR43","doi-asserted-by":"publisher","first-page":"e00017-19","DOI":"10.1128\/mSystems.00017-19","volume":"4","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis. mSystems. 2019;4:e00017-19.","journal-title":"mSystems"},{"key":"1487_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, et al. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9:21\u20139. https:\/\/doi.org\/10.1093\/advances\/nmx009.","journal-title":"Adv Nutr"},{"key":"1487_CR45","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10096-015-2355-4","volume":"34","author":"S Murugesan","year":"2015","unstructured":"Murugesan S, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis. 2015;34:1337\u201346.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1487_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jsbmb.2017.06.004","volume":"172","author":"N Lu","year":"2017","unstructured":"Lu N, et al. Butyric acid regulates progesterone and estradiol secretion via cAMP signaling pathway in porcine granulosa cells. J Steroid Biochem Mol Biol. 2017;172:89\u201397.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1487_CR47","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.7150\/ijbs.69771","volume":"18","author":"J Chen","year":"2022","unstructured":"Chen J, Fang Y, Xu Y, Sun H. Role of m6A modification in female infertility and reproductive system diseases. Int J Biol Sci. 2022;18:3592\u2013604. https:\/\/doi.org\/10.7150\/ijbs.69771.","journal-title":"Int J Biol Sci"},{"key":"1487_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01078-4","author":"E Huang","year":"2023","unstructured":"Huang E, Chen L. RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. Cell Commun Signal. 2023. https:\/\/doi.org\/10.1186\/s12964-023-01078-4.","journal-title":"Cell Commun Signal"},{"key":"1487_CR49","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1111\/jcmm.15807","volume":"24","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. Altered m6A modification is involved in up-regulated expression of FOXO3 in luteinized granulosa cells of non-obese polycystic ovary syndrome patients. J Cell Mol Med. 2020;24:11874\u201382.","journal-title":"J Cell Mol Med"},{"key":"1487_CR50","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1002\/jcp.26507","volume":"233","author":"C Ding","year":"2018","unstructured":"Ding C, et al. Increased N6-methyladenosine causes infertility is associated with FTO expression. J Cell Physiol. 2018;233:7055\u201366.","journal-title":"J Cell Physiol"},{"key":"1487_CR51","doi-asserted-by":"publisher","first-page":"107826","DOI":"10.1016\/j.celrep.2020.107826","volume":"31","author":"F Renoux","year":"2020","unstructured":"Renoux F, et al. The AP1 transcription factor Fosl2 promotes systemic autoimmunity and inflammation by repressing Treg development. Cell Rep. 2020;31:107826.","journal-title":"Cell Rep"},{"key":"1487_CR52","first-page":"1","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, et al. Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis. Nat Commun. 2022;13:1\u201316.","journal-title":"Nat Commun"},{"key":"1487_CR53","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/jcp.26149","volume":"233","author":"LN Dai","year":"2018","unstructured":"Dai LN, et al. Butyrate stimulates the growth of human intestinal smooth muscle cells by activation of yes-associated protein. J Cell Physiol. 2018;233:3119\u201328.","journal-title":"J Cell Physiol"},{"key":"1487_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"BCJM Fauser","year":"2004","unstructured":"Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"1487_CR55","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/s-0032-1328878","volume":"30","author":"RS Legro","year":"2012","unstructured":"Legro RS. Obesity and PCOS: Implications for diagnosis and treatment. Semin Reprod Med. 2012;30:496\u2013506.","journal-title":"Semin Reprod Med"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-023-01487-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:16:24Z","timestamp":1684156584000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-023-01487-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1186\/s13148-023-01487-9","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Nanjing University of Chinese Medicine (Ethics No. 2019NL-194-02). The experimental animal ethics committee of the Affiliated Hospital of Nanjing University of Chinese Medicine approved the animal experiment. All animal experiments were in line with the Guide for the Care and Use of Laboratory Animal by International Committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}